Naveen K Mittal, MD | Faculty Directory

Professional Background

Education

1996 - Postdoctoral Fellowship - Pediatric Gastroenterology - The University of Chicago Hospital
1993 - Residency - Pediatrics - Hahnemann University Hospital
1991 - Clinical Fellowship - Clinical Fellowship in Pedi-Gastroenterology - Bristol Royal Hospital
1990 - Residency - Pediatrics - South Cleveland Hospital, Department of Pediatrics
1988 - MD - Pediatrics - University of Delhi, Maulana Azad Medical College and Associated Hospitals
1988 - Residency - Pediatrics - Maulana Azad Medical College and Associated Hospitals
1985 - Residency - Surgery - Safdarjung Hospital, Department of Surgery
1985 - Residency - Pediatrics - Safdarjung Hospital, Department of Pediatrics
1984 - Internship - Pediatrics; Other Medical & Surgical Specialties - University College of Medical Sciences, Safdarjung Hospital
1983 - BM BS - Medicine - University of Delhi, University College of Medical Sciences

Appointments

9/2014 - Greehey Family Foundation Endowed Chair in Pediatric Gastroenterology - University of Texas Health Science Center at San AntonioSan Antonio
8/2014 - Medical Director - University Health System - Liver Transplant ProgramSan Antonio
11/2013 - Chief, Division of Pediatric Gastroenterology, Hepatology & Nutrition - University Health SystemSan Antonio
9/2009 - Professor/Clinical - University of Texas Health Science Center at San Antonio, Pediatrics, San Antonio
6/2009 - Chief, Division of Pediatric Gastroenterology - University of Texas Health Science Center at San Antonio, Pediatrics, San Antonio

Research & Grants

Research Profile

Grants

Private

Funding Agency Gilead Sciences, Inc. Title Chronic Hepatitis B - A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects with Chronic Hepatitis B Virus Infection Status Active Period 1/2016 - Present Role Co-Principal Investigator Grant Detail Funding Agency Gilead Sciences, Inc. Title Hepatitis C Virus Infection - A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials Status Active Period 1/2016 - Present Role Co-Principal Investigator Grant Detail Funding Agency Gilead Sciences, Inc. Title Hepatitis C Virus Infection - A Phase 2, Open-Label, Multicenter, Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV Infection Status Complete Period 1/2014 - 1/2018 Role Co-Principal Investigator Grant Detail

Publications

Abstract

Antonishek JD, Shiu V, Blanco CL, Mittal N. Genetic Mutation of Microvillus Inclusion Disease-Like Phenotype; 2017 Feb. (Journal of Investigative Medicine). Keller L, Mittal N, Blanco CL. Markers of Liver Disease Remain Elevated in Infants With Severe PNALD While on IV FISH Therapy With and Without Soy-Based Intralipid; 2016 May. (Pediatric Research). Sitabkhan A, Moreira AG, Mittal N, Jacob R, Tragus R, Blanco CL. Severe Allergic Colitis Can Present With Elemental Formula Feeds in Infants with Severe Intestinal Failure: A Case Series; 2016 Feb. (Journal of Investigative Medicine). Jacob, Bonagurio, Moreira, Green, Tragus, Keller, Sorrell, Sitabkhan, Mittal N, Blanco CL. Favorable Outcomes of Preterm Infants Treated with Fish Oil-Based Intravenous Lipid Emulsion for Parenteral Nutrition-Associated Liver Disease; 2014 May. (E-PAS).

Not Specified

Keller LM, Kerecman J, Goodman Z, Mittal N, Blanco CL. Markers of Hepatic Injury Correlate with Histological Changes of Neonatal Parenteral Nutrition Associated Liver Disease Journal of Investigative Medicine 2016 Feb;.